Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000302 · ClinicalTrials.gov registry record · Phase 3
Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
A Phase 3 study of Heroin Dependence, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 3
- Development phase
- 1
- Study location
NCT00000302 is a Phase 3 study of Heroin Dependence that has completed, run by National Institute on Drug Abuse (NIDA). The trial reports 1 study location across 1 state.
The verdict
NCT00000302, a Phase 3 study of Heroin Dependence, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1
- Study location
Study Summary
The purpose of this study is to compare liquid and tablet buprenorphine formulations.
Conditions Studied
Interventions
- DRUG Buprenorphine
Study Locations (1)
California
- Friends Research Institute - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000302
The ClinicalTrials.gov registry entry for NCT00000302 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heroin Dependence appearing as the primary indexed condition, and to 1 intervention - of which Buprenorphine is the first listed.
NCT00000302 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00000302 about?
NCT00000302 is a clinical study titled "Study Comparing Liquid and Tablet Buprenorphine Formulations - 5". The purpose of this study is to compare liquid and tablet buprenorphine formulations.
What is the current status of trial NCT00000302?
This trial is currently completed. It is a Phase 3 study.
What conditions does trial NCT00000302 study?
This clinical trial studies the following conditions: Heroin Dependence.
What interventions are being tested in trial NCT00000302?
The interventions under investigation include: Buprenorphine (DRUG).
Who is sponsoring clinical trial NCT00000302?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00000302 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heroin Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone
COMPLETED · Phase 3
-
Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1
COMPLETED · Phase 3
-
Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone
COMPLETED · Phase 3
-
Directly Administered HIV Therapy in Methadone Clinics
COMPLETED · Phase 2
-
Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens
COMPLETED · Phase 2
-
Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.